Patheon Italia S.p.A. – FDA 483, Nov 18, 2022
An FDA inspection of Patheon Italia S.p.A. in Monza, Italy, revealed significant deficiencies in aseptic processing, environmental monitoring, and data integrity. The firm failed to establish and follow procedures to prevent microbiological contamination of sterile drug products, lacked adequate controls for electronic data systems, and did not thoroughly investigate deviations or implement effective corrective actions. These issues indicate a high risk of product contamination and compromised data reliability.
ID · 6c026c16-362b-42d2-8eec-e7bdc8a9f447
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.